Abilify and Ataxia aggravated - a phase IV clinical study of FDA data
Ataxia aggravated is found among people who take Abilify, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Abilify and have Ataxia aggravated. It is created by eHealthMe based on reports of 90,519 people who have side effects when taking Abilify from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
90,519 people reported to have side effects when taking Abilify.
Among them, 114 people (0.13%) have Ataxia aggravated.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 88,864 Abilify users for its effectiveness, alternative drugs and more.
What is Ataxia aggravated?
Ataxia aggravated (serious loss of full control of bodily movements) is found to be associated with 754 drugs and 310 conditions by eHealthMe.
Number of Abilify and Ataxia aggravated reports submitted per year:
Time on Abilify when people have Ataxia aggravated *:
Gender of people who have Ataxia aggravated when taking Abilify*:
Age of people who have Ataxia aggravated when taking Abilify *:
Common drugs people take besides Abilify *:
Common side effects people have besides Ataxia aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and have Ataxia aggravated?Check whether Ataxia aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How severe was Ataxia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of aripiprazole:
Alternative drugs to, pros and cons of Abilify:
- Abilify (88,864 reports)
Common Abilify side effects:
Browse all side effects of Abilify:a b c d e f g h i j k l m n o p q r s t u v w x y z
Ataxia aggravated treatments and more:
- Ataxia aggravated (6 reports)
COVID vaccines that are related to Ataxia aggravated:
- Ataxia aggravated in Moderna COVID Vaccine
- Ataxia aggravated in Pfizer BioNTech Covid Vaccine
- Ataxia aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Ataxia aggravated:
All the drugs that are associated with Ataxia aggravated:
- Ataxia aggravated (754 drugs)
Common conditions associated with Ataxia aggravated:
All the conditions that are associated with Ataxia aggravated:
- Ataxia aggravated (310 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fiorinal and Upper Limb Fracture - now
- Haemorrhoids Aggravated and High Blood Cholesterol - 7 seconds ago
- Nutropin and Epinephrine drug interaction - 9 seconds ago
- Haemolytic Anaemia and High Blood Cholesterol - 9 seconds ago
- Nervousness and Torsade De Pointes - 15 seconds ago
- Novolog and Flonase Allergy Relief drug interaction - 16 seconds ago
- Haemorrhage and High Blood Cholesterol - 17 seconds ago
- Haemoglobin Abnormal and High Blood Cholesterol - 18 seconds ago
- Bumetanide vs. Chlorthalidone - 26 seconds ago
- Keytruda and Mirtazapine drug interaction - 27 seconds ago